Avricore Health Inc (AVCR) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Avricore Health Inc (AVCR) has a cash flow conversion efficiency ratio of -0.761x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-296.48K ≈ $-214.47K USD) by net assets (CA$389.56K ≈ $281.80K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See defensive interval ratio of Avricore Health Inc to measure how many days the company can operate on defensive assets alone.
Avricore Health Inc - Cash Flow Conversion Efficiency Trend (2000–2025)
This chart illustrates how Avricore Health Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Avricore Health Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Avricore Health Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
McChip Resources Inc
V:MCS
|
-0.031x |
|
Foresight Autonomous Holdings Ltd
TA:FRSX
|
-0.464x |
|
Yu Group PLC
LSE:YU
|
0.203x |
|
Fragbite Group AB
ST:FRAG
|
-0.211x |
|
Kakel Max AB (publ)
ST:KAKEL
|
-0.012x |
|
Capstone Holding Corp. Common Stock
NASDAQ:CAPS
|
-0.249x |
|
XP Chemistries AB
ST:XPC
|
-0.113x |
|
Hubify Ltd
AU:HFY
|
0.055x |
Annual Cash Flow Conversion Efficiency for Avricore Health Inc (2000–2025)
The table below shows the annual cash flow conversion efficiency of Avricore Health Inc from 2000 to 2025. For the full company profile with market capitalisation and key ratios, see Avricore Health Inc (AVCR) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CA$389.56K ≈ $281.80K |
CA$-789.93K ≈ $-571.43K |
-2.028x | -497.17% |
| 2024-12-31 | CA$1.97 Million ≈ $1.42 Million |
CA$1.00 Million ≈ $726.72K |
0.511x | +55.31% |
| 2023-12-31 | CA$2.01 Million ≈ $1.45 Million |
CA$660.40K ≈ $477.73K |
0.329x | +247.46% |
| 2022-12-31 | CA$1.96 Million ≈ $1.42 Million |
CA$-437.83K ≈ $-316.72K |
-0.223x | +60.32% |
| 2021-12-31 | CA$2.20 Million ≈ $1.59 Million |
CA$-1.23 Million ≈ $-892.77K |
-0.562x | -132.79% |
| 2020-12-31 | CA$-714.04K ≈ $-516.53K |
CA$-1.22 Million ≈ $-884.99K |
1.713x | +16.18% |
| 2019-12-31 | CA$-465.45K ≈ $-336.70K |
CA$-686.41K ≈ $-496.54K |
1.475x | +175.74% |
| 2018-12-31 | CA$885.97K ≈ $640.89K |
CA$-1.73 Million ≈ $-1.25 Million |
-1.947x | -175.22% |
| 2017-12-31 | CA$2.50 Million ≈ $1.81 Million |
CA$-1.77 Million ≈ $-1.28 Million |
-0.707x | +34.26% |
| 2016-12-31 | CA$1.92 Million ≈ $1.39 Million |
CA$-2.06 Million ≈ $-1.49 Million |
-1.076x | -81.28% |
| 2015-12-31 | CA$3.25 Million ≈ $2.35 Million |
CA$-1.93 Million ≈ $-1.39 Million |
-0.594x | -34.10% |
| 2014-12-31 | CA$3.35 Million ≈ $2.43 Million |
CA$-1.48 Million ≈ $-1.07 Million |
-0.443x | +45.59% |
| 2013-12-31 | CA$663.10K ≈ $479.67K |
CA$-539.52K ≈ $-390.28K |
-0.814x | -129.81% |
| 2012-12-31 | CA$436.69K ≈ $315.89K |
CA$-154.61K ≈ $-111.84K |
-0.354x | -897.35% |
| 2011-12-31 | CA$-1.32 Million ≈ $-955.71K |
CA$-58.66K ≈ $-42.44K |
0.044x | -92.97% |
| 2010-12-31 | CA$-1.07 Million ≈ $-771.49K |
CA$-673.34K ≈ $-487.08K |
0.631x | +104.18% |
| 2009-12-31 | CA$239.30K ≈ $173.10K |
CA$-3.61 Million ≈ $-2.61 Million |
-15.095x | -2699.35% |
| 2008-12-31 | CA$1.73 Million ≈ $1.25 Million |
CA$-930.62K ≈ $-673.20K |
-0.539x | -52.29% |
| 2007-12-31 | CA$2.48 Million ≈ $1.79 Million |
CA$-876.72K ≈ $-634.21K |
-0.354x | +25.57% |
| 2006-12-31 | CA$779.90K ≈ $564.17K |
CA$-371.02K ≈ $-268.39K |
-0.476x | +76.21% |
| 2005-12-31 | CA$157.37K ≈ $113.84K |
CA$-314.66K ≈ $-227.62K |
-1.999x | -33.90% |
| 2004-12-31 | CA$271.03K ≈ $196.06K |
CA$-404.72K ≈ $-292.77K |
-1.493x | -58.17% |
| 2003-12-31 | CA$800.22K ≈ $578.87K |
CA$-755.46K ≈ $-546.49K |
-0.944x | -1330.14% |
| 2002-12-31 | CA$182.98K ≈ $132.37K |
CA$14.04K ≈ $10.16K |
0.077x | +119.37% |
| 2001-12-31 | CA$184.42K ≈ $133.41K |
CA$-73.06K ≈ $-52.85K |
-0.396x | -202.19% |
| 2000-12-31 | CA$79.95K ≈ $57.83K |
CA$-10.48K ≈ $-7.58K |
-0.131x | -- |
About Avricore Health Inc
Avricore Health Inc. engages in the health data and point-of-care technologies business. It provides HealthTab, a turnkey point-of-care testing platform for pharmacies that can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018… Read more